Peel Hunt Reiterates Buy Rating for Genedrive (GDR)

Peel Hunt restated their buy rating on shares of Genedrive (LON:GDR) in a research report released on Friday morning.

Genedrive opened at GBX 31.90 ($0.42) on Friday, according to Marketbeat Ratings. Genedrive has a 1 year low of GBX 25 ($0.33) and a 1 year high of GBX 44.50 ($0.59).

Genedrive Company Profile

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Read More: What kind of dividend yield to CEF’s pay?

Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with's FREE daily email newsletter.

Leave a Reply